Protea Biosciences Revenue, Profits - PRGBQ Annual Income Statement

Add to My Stocks
$0.01 $0 (0%) PRGBQ stock closing price Mar 21, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Protea Biosciences stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $2.44M for 2016 impacts the PRGBQ stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2016 is $2.44M and has increased from $2M year on year as is evident when you compare the latest figures in the latest Protea Biosciences profit and loss statement with those of the prior corresponding period. Also see Protea Biosciences assets and Protea Biosciences free cash flow for a complete valuation of PRGBQ stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011
Protea Biosciences Revenues or Net Sales
Cost Of Goods Sold (COGS)1.7M-----
Protea Biosciences Gross Profit
Research & Development Expense-1.47M2.85M2.77M4.59M6.24M
Selling General & Admin Expense5.63M6.94M8.73M8.77M5.21M5.24M
Income Before Depreciation Depletion Amortization-5.49M-7.14M-10.69M-10.32M-8.98M-10.77M
Depreciation Depletion Amortization------
Non Operating Income-8.18M-0.81M-0.03M-0.34M-0.01M-
Interest Expense1.96M1.61M----
Protea Biosciences Pretax Income
Provision for Income Taxes------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-15.64M-9.57M-11.47M-11.41M-9.53M-11.49M
Extraordinary Items & Discontinued Operations------
Protea Biosciences Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS2.72M2.19M----
Average Shares used to compute Basic EPS2.72M2.19M----
Income Before Nonrecurring Items-5.97M-9.57M----
Income from Nonrecurring Items-9.68M-----
Protea Biosciences Earnings Per Share Basic Net
Protea Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-2.50-4.50----
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our MEDPACE HLDGS financial analysis

Protea Biosciences stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that PRGBQ stock has a topline or revenue of $2.44M for 2016 as per this Protea Biosciences revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Protea Biosciences try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the PRGBQ income statement, one can check the Protea Biosciences historical stock prices to check how the price has moved with time.

Protea Biosciences Income Statement - Key Financial Ratios

Annual Income Statements - Protea Biosciences Group Inc Industry Peers

MEDPACE HLDGS income statement, Millenium Healthcare income statement, Patient Portal income statement